{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:55:25Z","timestamp":1790142925085,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["KJ2014A117"],"award-info":[{"award-number":["KJ2014A117"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.intimp.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T12:57:51Z","timestamp":1533733071000},"page":"183-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt\/\u03b2-catenin signaling pathway, c-Myc and cyclin D1"],"prefix":"10.1016","volume":"63","author":[{"given":"Chong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Ming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drudis.2015.10.015","article-title":"Emerging therapeutic targets for the treatment of hepatic fibrosis [J]","volume":"21","author":"Fagone","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"20","key":"10.1016\/j.intimp.2018.08.005_bb0010","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection [J]","volume":"368","author":"Liang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.005_bb0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis [J]","volume":"56","author":"Ellis","year":"2012","journal-title":"J. Hepatol."},{"issue":"46","key":"10.1016\/j.intimp.2018.08.005_bb0020","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.M117.793794","article-title":"Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling [J]","volume":"292","author":"Sato-Matsubara","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2018.08.005_bb0025","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling [J]","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis [J]","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.intimp.2018.08.005_bb0035","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology [J]","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2018.08.005_bb0040","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.29627","article-title":"MicroRNA-21 and dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis [J]","volume":"67","author":"Caviglia","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.intimp.2018.08.005_bb0045","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation [J]","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"49","key":"10.1016\/j.intimp.2018.08.005_bb0050","doi-asserted-by":"crossref","first-page":"21110","DOI":"10.1073\/pnas.1004708107","article-title":"Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction [J]","volume":"107","author":"He","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"32","key":"10.1016\/j.intimp.2018.08.005_bb0055","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1001520107","article-title":"Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis [J]","volume":"107","author":"Henderson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2008060566","article-title":"Wnt\/beta-catenin signaling promotes renal interstitial fibrosis [J]","volume":"20","author":"He","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00198-017-4309-4","article-title":"Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis [J]","volume":"29","author":"Makitie","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2018.08.005_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2016.11.002","article-title":"Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells [J]","volume":"80","author":"Cai","year":"2016","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2018.08.005_bb0075","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","article-title":"Beta-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/beta-catenin signaling inhibits hepatic stellate cell activation [J]","volume":"9","author":"Ge","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3892\/mmr.2013.1587","article-title":"Protective effect of the herbal medicine Ganfukang against carbon tetrachlorideinduced liver fibrosis in rats [J]","volume":"8","author":"Zhang","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2007.12.085","article-title":"Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells [J]","volume":"367","author":"Kordes","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0090","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5009\/gnl.2014.8.3.282","article-title":"Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt\/\u03b2-catenin signaling pathway [J]","volume":"8","author":"Li","year":"2014","journal-title":"Gut and Liver"},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000084722","article-title":"Variceal bleeding: pharmacological therapy [J]","volume":"23","author":"Bosch","year":"2005","journal-title":"Dig. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18632\/oncotarget.6447","article-title":"MicroRNA-17-5p-activated Wnt\/beta-catenin pathway contributes to the progression of liver fibrosis [J]","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0105","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","article-title":"Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis [J]","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2008.06.011","article-title":"Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair [J]","volume":"58","author":"Iredale","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3350\/cmh.2014.20.3.228","article-title":"Prediction of fibrosis progression in chronic viral hepatitis [J]","volume":"20","author":"Wong","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0035-1550055","article-title":"Antifibrotic therapies in the liver [J]","volume":"35","author":"Mehal","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.intimp.2018.08.005_bb0125","first-page":"648915","article-title":"Mechanisms and biomarkers of apoptosis in liver disease and fibrosis [J]","volume":"2012","author":"Chakraborty","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2018.08.005_bb0130","doi-asserted-by":"crossref","first-page":"7629724","DOI":"10.1155\/2016\/7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis [J]","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis [J]","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0140","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury [J]","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","article-title":"Cellular sources of extracellular matrix in hepatic fibrosis [J]","volume":"12","author":"Wells","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.005_bb0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution [J]","volume":"112","author":"Henderson","year":"2007","journal-title":"Clin. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2018.08.005_bb0155","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","article-title":"Extracellular matrix degradation in liver fibrosis: biochemistry and regulation [J]","volume":"1832","author":"Iredale","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0160","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.28948","article-title":"The origin of fibrogenic myofibroblasts in fibrotic liver [J]","volume":"65","author":"Kisseleva","year":"2017","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2018.08.005_bb0165","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1755-1536-5-S1-S17","article-title":"Origin of myofibroblasts in liver fibrosis [J]","volume":"5","author":"Brenner","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.yexcr.2017.02.038","article-title":"Modulation of hepatic stellate cells and reversibility of hepatic fibrosis [J]","volume":"352","author":"Huang","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yexcr.2017.07.025","article-title":"Frizzled-7 mediates TGF-beta-induced pulmonary fibrosis by transmitting non-canonical Wnt signaling [J]","volume":"359","author":"Guan","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yexcr.2017.07.018","article-title":"Cdc42-interacting protein 4 silencing relieves pulmonary fibrosis in STZ-induced diabetic mice via the Wnt\/GSK-3beta\/beta-catenin pathway [J]","volume":"359","author":"Zhang","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0185","first-page":"174","article-title":"FGF23 promotes renal interstitial fibrosis by activating beta-catenin [J]","volume":"22","author":"Zhu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000430128","article-title":"HuangQi decoction improves renal tubulointerstitial fibrosis in mice by inhibiting the up-regulation of Wnt\/beta-catenin signaling pathway [J]","volume":"36","author":"Jiang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/kisup.2014.16","article-title":"Wnt\/beta-catenin signaling and kidney fibrosis [J]","volume":"4","author":"Tan","year":"2014","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.intimp.2018.08.005_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fgene.2017.00183","article-title":"Wnt\/beta-catenin signaling pathway regulates specific lncRNAs that impact dermal fibroblasts and skin fibrosis [J]","volume":"8","author":"Mullin","year":"2017","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41598-017-00282-w","article-title":"Selective inhibitor of Wnt\/beta-catenin\/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model [J]","volume":"7","author":"Tokunaga","year":"2017","journal-title":"Sci. Rep."},{"issue":"28","key":"10.1016\/j.intimp.2018.08.005_bb0210","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review [J]","volume":"19","author":"Sanchez-Valle","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.33549\/physiolres.932289","article-title":"Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases [J]","volume":"61","author":"Guo","year":"2012","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2018.08.005_bb0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ydbio.2013.08.007","article-title":"Loss of Xenopus cadherin-11 leads to increased Wnt\/beta-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest [J]","volume":"383","author":"Koehler","year":"2013","journal-title":"Dev. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2018.08.005_bb0225","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model [J]","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.005_bb0230","first-page":"7118","article-title":"Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt\/beta-catenin signaling pathway [J]","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.intimp.2018.08.005_bb0235","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/art.34425","article-title":"A Wnt\/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes [J]","volume":"64","author":"Ma","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2018.08.005_bb0240","first-page":"126","article-title":"Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt\/P-catenin pathway [J]","volume":"64","author":"Chen","year":"2009","journal-title":"Pharmazie"},{"issue":"127","key":"10.1016\/j.intimp.2018.08.005_bb0245","first-page":"1639","article-title":"Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3beta, a Wnt\/beta-catenin pathway modulator [J]","volume":"60","author":"Wang","year":"2013","journal-title":"Hepato-Gastroenterology"},{"issue":"4","key":"10.1016\/j.intimp.2018.08.005_bb0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1478-3231.2005.01057.x","article-title":"Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells [J]","volume":"25","author":"Lang","year":"2005","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.intimp.2018.08.005_bb0255","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3892\/mmr.2013.1385","article-title":"The mechanism through which octreotide inhibits hepatic stellate cell activity [J]","volume":"7","author":"Wang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2018.08.005_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molimm.2016.05.018","article-title":"MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt\/beta-catenin pathway [J]","volume":"75","author":"Zhou","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2018.08.005_bb0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2017.11.010","article-title":"miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis [J]","volume":"10","author":"Zhou","year":"2018","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2006.03.016","article-title":"Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation [J]","volume":"45","author":"Jiang","year":"2006","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2018.08.005_bb0275","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbadis.2017.12.001","article-title":"Inhibition of canonical WNT signaling pathway by beta-catenin\/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12 [J]","volume":"1864","author":"Akcora","year":"2018","journal-title":"Biochim. Biophys. Acta"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918303825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918303825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:11Z","timestamp":1761585011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918303825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":55,"alternative-id":["S1567576918303825"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.08.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt\/\u03b2-catenin signaling pathway, c-Myc and cyclin D1","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}